Kıraz, KemalÇörtük, MustafaZıtounı, BurcakÇetinkaya, Erdem AtalayBenli, Ali Ramazan2024-09-292024-09-2920161303-2283https://doi.org/10.17098/amj.26198https://search.trdizin.gov.tr/tr/yayin/detay/317174https://hdl.handle.net/20.500.14619/10347Objectives: Sleep apnea syndrome (OSA) is closely associated with obesity and cardiovascular diseases.OSA disrupts neurocognitive functioning and negatively affects quality of life. Use of a positive airwaypressure (PAP) device remains the gold standard treatment for OSA. We used the Short Form?36 (SF?36)instrument to measure quality?of?life changes in PAP?treated patients in Turkey.Materials and Methods: The present study included 67 (52 male) consecutive OSA patients treated witha PAP device. Each subject underwent overnight full?laboratory polysomnographic examination. The SF?36 scores of patients given a PAP device were measured before they commenced using the device and 6–18months later. Results: Appropriate use of PAP devices improved quality of life as evidenced by improvement on allparameters of the SF?36 instrument quality?of?life scale (P<0.05). Conclusion: We found that PAP therapy significantly improved quality of life. This study is the first inTurkey to use the SF?36 on this subject.eninfo:eu-repo/semantics/openAccessHalk ve Çevre SağlığıTemel Sağlık HizmetleriArticle10.17098/amj.26198353434731717416